MedPath

A one year study to determine the maternal and fetal outcomes in pregnant women with heart disease

Not Applicable
Conditions
Health Condition 1: O098- Supervision of other high risk pregnancies
Registration Number
CTRI/2019/03/018083
Lead Sponsor
Dr Lameez Khan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All pregnant women more than 20 weeks period of gestation admitted with known or newly diagnosed cardiac disease (congenital or acquired) whether symptomatic or asymptomatic

Exclusion Criteria

- all pregnant women with cardiac disease admitted for termination of pregnancy

- cardiac disease in which pregnancy is contraindicated like Eisenmengers syndrome

incomplete records of the patient

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To determine the feto-maternal outcomes in all pregnant women with heart diseaseTimepoint: Mode of delivery <br/ ><br>Maternal outcome and complications - CHF,AF,IE, Cardiac complications <br/ ><br>Fetal outcomes- NICU admission , SGA, IUGR, Prematurity, birth asphyxia, birth weight, IUFD
Secondary Outcome Measures
NameTimeMethod
To determine the feto-maternal outcomes in all pregnant women with heart diseaseTimepoint: Mode of delivery <br/ ><br>Maternal outcome and complications - CHF,AF,IE, Cardiac complications <br/ ><br>Fetal outcomes- NICU admission , SGA, IUGR, Prematurity, birth asphyxia, birth weight, IUFD
© Copyright 2025. All Rights Reserved by MedPath